---  
layout: startup_page  
title: "Tubulis"  
id: "tubulis.com"  
permalink: "/tubulistubulis.com03142024/"  
website: "https://tubulis.com/"  
funding_round: "Series B2"  
funding_amount: "€128M"  
investors: "EQT Life Sciences, Nextech Invest Ltd, Frazier Life Sciences, Deep Track Capital, Andera Partners, BioMedPartners, Fund+, Bayern Kapital, Evotec, coparion, Seventure Partners, OCCIDENT, High-Tech Gründerfonds (HTGF)"  
about: "Tubulis develops antibody-drug conjugates (ADCs) with indication-tailored targeting molecules and payloads. Their proprietary platform allows for customizable ADCs with superior properties, addressing key bottlenecks in ADC development. The company focuses on solid tumor indications."  
markets: "Biotechnology, Oncology, Pharmaceuticals, Therapeutics, Life Science, Drug Discovery"  
hq: "Munich, Bavaria, Germany"  
founded_year: "2012"  
linkedin: "https://www.linkedin.com/company/tubulis/"  
twitter: "https://twitter.com/tubulis_gmbh"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/tubulis-technologies"  
pitchbook: "https://pitchbook.com/profiles/company/183642-31"  

date_display: "14-Mar-2024"  
date: "2024-03-14"

# SEO Optimization  
meta_title: "Tubulis - Series B2 Funding (€128M)"  
meta_description: "Tubulis, Tubulis develops antibody-drug conjugates (ADCs) with indication-tailored targeting molecules and payloads. Their proprietary platform allows for cust..."  
meta_keywords: "Tubulis, Biotechnology, Oncology, Pharmaceuticals, Therapeutics, Life Science, Drug Discovery, Series B2 funding"  
canonical_url: "https://startup.projectstartups.com/tubulistubulis.com03142024/"  
---